Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by 2027

Posted by soham patil on December 11th, 2020

Global Nuclear Medicine/Radiopharmaceuticals Market was valued at USD 6.5 billion in 2019 which is expected to reach USD 12.25 billion by 2027 at a CAGR 9.88%.

Nuclear medicines/radiopharmaceuticals are radioactive compounds which are administered to patients and monitored via special imaging devices. These are used to diagnosis and therapeutic purposes. Nuclear medicines or radiopharmaceutical components are composed of organic molecules with radioisotopes. Radioisotopes emits gamma rays are used for diagnosis.

Request Sample Copy of this Report @

Market Drivers

Increase in incidences of chronic diseases like cancer is the key driving factor which is expected to boost the global nuclear medicine/ radiopharmaceuticals market growth. For instance, in 2018, according to World Health Organization (WHO) around 9.6 million people were dead due to cancer across the world. Also, increase in prevalence of cardiovascular diseases will have the positive impact on global nuclear medicine/ radiopharmaceuticals market growth. Furthermore, increase in technological advancements is expected to propel the global nuclear medicine/ radiopharmaceuticals market growth.

Market Restraints

However, short life of radiopharmaceuticals is the restraining factor for market which is expected to hamper the global nuclear/ radiopharmaceuticals market growth. Also, logistical difficulties, supply shortage and lack of qualified professionals will affect the global nuclear medicine/ radiopharmaceuticals market growth.

Market Key Players

Various key players are discussed in this report such as Iba Molecular, Advanced Accelerator Applications S.A., Nordion, Inc, Eczacibasi-Monrol Nuclear Products, Bracco Imaging S.P.A, Bayer AG, Lantheus Medical Imaging, Inc., GE Healthcare, Mallinckrodt PLC, and Cardinal Health, Inc.

Market Taxonomy

By Type

  • Diagnostic Nuclear Medicine
  • SPECT Radiopharmaceuticals
  • Tc-99m
  • Tl-201
  • Ga-67
  • Others
  • PET Radiopharmaceuticals
  • F-18
  • Rubidium-82
  • Others

By Procedure

  • Brachytherapy Isotopes
  • Alpha Emitters
  • Beta Emitters
  • Therapeutic Procedures
  • PET Radiopharmaceuticals
  • SPECT Radiopharmaceuticals

By Application

  • Cardiology
  • Oncology
  • Neurology
  • Thyroid
  • Others

By Region

  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East & Africa

Get discount on this report @

About Us:-

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

Contact Person:-

Vishal Thakur

Research Support Specialist

QualiKet Research

6060 N Central Expy #500, TX 75204, U.S.A



Like it? Share it!

soham patil

About the Author

soham patil
Joined: September 1st, 2020
Articles Posted: 235

More by this author